Report Detail
Global Talazoparib Tosylate Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4702041 |
- 01 June, 2026 |
- Global |
- 75 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Talazoparib Tosylate market size was valued at US$ 2325 million in 2025 and is forecast to a readjusted size of US$ 4576 million by 2032 with a CAGR of 10.4% during review period.
In 2025, global Talazoparib Tosylate production reached approximately 1.2 million bottlesTalazoparib Tosylate is a highly selective oral Poly Adenosine Diphosphate Ribose Polymerase (PARP) inhibitor. It mainly induces tumor cell apoptosis by inhibiting PARP enzyme activity and blocking the repair process of damaged DNA. Clinically, it is commonly applied to the targeted treatment of malignant tumors such as advanced breast cancer with BRCA gene mutations. With potent anti-tumor activity and favorable oral tolerability, this drug can effectively delay disease progression. It provides a long-acting precise treatment option for patients with tumors related to hereditary gene mutations, and has become one of the essential individualized anti-tumor drugs in clinical practice
Talazoparib Tosylate is a new-generation highly selective PARP inhibitor. With a unique mechanism of action and definite clinical benefits, it occupies an important position and enjoys broad development prospects in the field of global anti-tumor targeted therapy. Approved in many countries and regions for indications including BRCA-mutated advanced breast cancer and HRR-mutated metastatic castration-resistant prostate cancer, this drug has seen continuous growth in clinical demand and steady improvement in market penetration. At present, the market is dominated by original research enterprises. As patent expiration approaches, domestic generic pharmaceutical companies have accelerated their layout, and the future competitive landscape will gradually become diversified. Meanwhile, the drug has not yet been included in medical insurance, resulting in a heavy economic burden for patients and restricting clinical accessibility to a certain extent. Uncertainty in indication expansion, competitive pressure from similar PARP inhibitors, and uneven popularity of genetic testing before medication also pose major challenges to market development. In the long run, with the deepening of precision medical concepts, continuous exploration of combination therapy regimens and the expectation of medical insurance coverage, Talazoparib Tosylate is expected to further explore potential therapeutic fields on the basis of consolidating core indications, so as to achieve sustained market expansion and value release.
This report is a detailed and comprehensive analysis for global Talazoparib Tosylate market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Talazoparib Tosylate market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Talazoparib Tosylate market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Talazoparib Tosylate market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Talazoparib Tosylate market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Talazoparib Tosylate
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Talazoparib Tosylate market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Talazoparib Tosylate market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
0.25 Mg Per Capsule
1 Mg Per Capsule
Market segment by Combination Therapy
Talazoparib Tosylate And Atezolizumab
Talazoparib Tosylate And Enzalutamide
Market segment by Sales Channel
Hospital
Retail
Online
Market segment by Application
BRCA-Mutated Advanced Breast Cancer
HRR-Mutated Metastatic Prostate Cancer
Hereditary Breast And Ovarian Syndrome
Others
Major players covered
Pfizer
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Talazoparib Tosylate product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Talazoparib Tosylate, with price, sales quantity, revenue, and global market share of Talazoparib Tosylate from 2021 to 2026.
Chapter 3, the Talazoparib Tosylate competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Talazoparib Tosylate breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Talazoparib Tosylate market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Talazoparib Tosylate.
Chapter 14 and 15, to describe Talazoparib Tosylate sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Talazoparib Tosylate Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 0.25 Mg Per Capsule
- 1.3.3 1 Mg Per Capsule
- 1.4 Market Analysis by Combination Therapy
- 1.4.1 Overview: Global Talazoparib Tosylate Consumption Value by Combination Therapy: 2021 Versus 2025 Versus 2032
- 1.4.2 Talazoparib Tosylate And Atezolizumab
- 1.4.3 Talazoparib Tosylate And Enzalutamide
- 1.5 Market Analysis by Sales Channel
- 1.5.1 Overview: Global Talazoparib Tosylate Consumption Value by Sales Channel: 2021 Versus 2025 Versus 2032
- 1.5.2 Hospital
- 1.5.3 Retail
- 1.5.4 Online
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global Talazoparib Tosylate Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 BRCA-Mutated Advanced Breast Cancer
- 1.6.3 HRR-Mutated Metastatic Prostate Cancer
- 1.6.4 Hereditary Breast And Ovarian Syndrome
- 1.6.5 Others
- 1.7 Global Talazoparib Tosylate Market Size & Forecast
- 1.7.1 Global Talazoparib Tosylate Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Talazoparib Tosylate Sales Quantity (2021-2032)
- 1.7.3 Global Talazoparib Tosylate Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Pfizer
- 2.1.1 Pfizer Details
- 2.1.2 Pfizer Major Business
- 2.1.3 Pfizer Talazoparib Tosylate Product and Services
- 2.1.4 Pfizer Talazoparib Tosylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Pfizer Recent Developments/Updates
3 Competitive Environment: Talazoparib Tosylate by Manufacturer
- 3.1 Global Talazoparib Tosylate Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Talazoparib Tosylate Revenue by Manufacturer (2021-2026)
- 3.3 Global Talazoparib Tosylate Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Talazoparib Tosylate by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Talazoparib Tosylate Manufacturer Market Share in 2025
- 3.4.3 Top 6 Talazoparib Tosylate Manufacturer Market Share in 2025
- 3.5 Talazoparib Tosylate Market: Overall Company Footprint Analysis
- 3.5.1 Talazoparib Tosylate Market: Region Footprint
- 3.5.2 Talazoparib Tosylate Market: Company Product Type Footprint
- 3.5.3 Talazoparib Tosylate Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Talazoparib Tosylate Market Size by Region
- 4.1.1 Global Talazoparib Tosylate Sales Quantity by Region (2021-2032)
- 4.1.2 Global Talazoparib Tosylate Consumption Value by Region (2021-2032)
- 4.1.3 Global Talazoparib Tosylate Average Price by Region (2021-2032)
- 4.2 North America Talazoparib Tosylate Consumption Value (2021-2032)
- 4.3 Europe Talazoparib Tosylate Consumption Value (2021-2032)
- 4.4 Asia-Pacific Talazoparib Tosylate Consumption Value (2021-2032)
- 4.5 South America Talazoparib Tosylate Consumption Value (2021-2032)
- 4.6 Middle East & Africa Talazoparib Tosylate Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Talazoparib Tosylate Sales Quantity by Type (2021-2032)
- 5.2 Global Talazoparib Tosylate Consumption Value by Type (2021-2032)
- 5.3 Global Talazoparib Tosylate Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Talazoparib Tosylate Sales Quantity by Application (2021-2032)
- 6.2 Global Talazoparib Tosylate Consumption Value by Application (2021-2032)
- 6.3 Global Talazoparib Tosylate Average Price by Application (2021-2032)
7 North America
- 7.1 North America Talazoparib Tosylate Sales Quantity by Type (2021-2032)
- 7.2 North America Talazoparib Tosylate Sales Quantity by Application (2021-2032)
- 7.3 North America Talazoparib Tosylate Market Size by Country
- 7.3.1 North America Talazoparib Tosylate Sales Quantity by Country (2021-2032)
- 7.3.2 North America Talazoparib Tosylate Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Talazoparib Tosylate Sales Quantity by Type (2021-2032)
- 8.2 Europe Talazoparib Tosylate Sales Quantity by Application (2021-2032)
- 8.3 Europe Talazoparib Tosylate Market Size by Country
- 8.3.1 Europe Talazoparib Tosylate Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Talazoparib Tosylate Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Talazoparib Tosylate Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Talazoparib Tosylate Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Talazoparib Tosylate Market Size by Region
- 9.3.1 Asia-Pacific Talazoparib Tosylate Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Talazoparib Tosylate Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Talazoparib Tosylate Sales Quantity by Type (2021-2032)
- 10.2 South America Talazoparib Tosylate Sales Quantity by Application (2021-2032)
- 10.3 South America Talazoparib Tosylate Market Size by Country
- 10.3.1 South America Talazoparib Tosylate Sales Quantity by Country (2021-2032)
- 10.3.2 South America Talazoparib Tosylate Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Talazoparib Tosylate Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Talazoparib Tosylate Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Talazoparib Tosylate Market Size by Country
- 11.3.1 Middle East & Africa Talazoparib Tosylate Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Talazoparib Tosylate Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Talazoparib Tosylate Market Drivers
- 12.2 Talazoparib Tosylate Market Restraints
- 12.3 Talazoparib Tosylate Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Talazoparib Tosylate and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Talazoparib Tosylate
- 13.3 Talazoparib Tosylate Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Talazoparib Tosylate Typical Distributors
- 14.3 Talazoparib Tosylate Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Talazoparib Tosylate. Industry analysis & Market Report on Talazoparib Tosylate is a syndicated market report, published as Global Talazoparib Tosylate Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Talazoparib Tosylate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
